New York, December 19, 2023 – NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) has been granted FDA clearance for its Investigational New Drug Application (IND) for NRX-101 for the treatment of complicated Urinary Tract infections (cUTI). The company’s shares surged 25% in trading on Monday following the news. NRx Pharmaceuticals, Inc. Complicated Urinary Tract Infections afflict approximately 3 million Americans each … Continue reading “NRx Pharmaceuticals Secures IND for Urinary Tract Infection Treatment”
Author: Sophia Vida
Sofia has been writing for major news outlets for over 15 years. In her spare time she enjoys hiking, walking her dogs, and going to concerts.
Breaking News
PPJ Healthcare Enterprises, Inc. signed new Billing Accounts
TAMPA, FLORIDA, December 19, 2023 – PPJ Healthcare Enterprises Inc. (OTC Pink: PPJE) has announced…
December 19, 2023
Breaking News
BioStem Technologies Appoints Executive Leader Patrick Daly to Board of Directors
POMPANO BEACH, FLORIDA, December 19, 2023 – BioStem Technologies Inc. (OTC: BSEM), a leading regenerative…
December 19, 2023
Breaking News
PRISM Analysis: Why Did Battalion Oil Shares Soar on Friday?
NEW YORK, NY, December 18, 2023 – Shares in Battalion Oil Corporation (NYSE American: BATL) surged more…
December 18, 2023
Breaking News
MindMed Advances Treatment for Generalized Anxiety Disorder
NEW YORK, NY, December 18, 2023 – Biopharmaceutical company, Mind Medicine (Nasdaq: MNMD) has announced positive results from…
December 18, 2023
Breaking News
SinglePoint Rings the Opening Bell at Cboe Global Markets Exchange
Phoenix, AZ, December 18, 2023 – SinglePoint Inc. (Cboe: SING) (“SinglePoint” or the “Company”), a renewable…
December 18, 2023
Breaking News
PRISM AdTech & Media Company Spotlight: Creative Realities Illuminates the Future of Experiential Design
In the fast-paced landscape of experiential design and technology, Creative Realities Inc. seamlessly integrates the…
December 16, 2023
Breaking News
PRISM MediaWire – Weekly Press Resume – Dec. 11 to Dec. 15, 2023
New York, December 15, 2023 PRISM MediaWire – Weekly Press Resume Dec. 11 to Dec.…
December 15, 2023
Breaking News
“Exceptional Result”: NeuroSense Therapeutics Reports New Positive Data from ALS Trial
NEW YORK, NY, December 15, 2023 – NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) has reported additional positive efficacy data from its…
December 15, 2023
Breaking News
CORRECTION FROM SOURCE: SinglePoint, Inc. – The Inaugural US Company to List on Cboe BZX Exchange
Correcting number of shares in previous Press Release SinglePoint, Inc. common stock to begin trading…
December 15, 2023
Breaking News
SinglePoint, Inc.–The Inaugural US Company to List on Cboe BZX Exchange
SinglePoint, Inc. common stock to begin trading on Cboe BZX Exchange on December 15th, 2023,…
December 15, 2023
Breaking News
Verde Bio Holdings Announces Entry Into Business Combination Agreement with SensaSure Technologies, Inc.
Transaction will provide Formation Minerals Inc., a wholly-owned subsidiary of SensaSure Technologies, Inc. (OTCQB: SSTC)…
December 15, 2023
Breaking News
SinglePoint Announces Pricing of $4 Million Public Offering, Uplisting to Cboe Global Markets and Reverse Stock Split
Phoenix, AZ, December 15, 2023 – SinglePoint Inc. formerly (OTC: SING) now trades as (Cboe:…
December 15, 2023
Breaking News
PRISM AdTech & Media Company Spotlight: Creative Realities (CREX) Illuminates the Future of Experiential Design
NEW YORK, NY, December 14, 2023 – In the fast-paced landscape of experiential design and…
December 14, 2023